Compounds > tris(dibenzylideneacetone)dipalladium
Page last updated: 2024-11-11

tris(dibenzylideneacetone)dipalladium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tris(dibenzylideneacetone)dipalladium: N-myristoyltransferase-1 inhibitor that is effective against melanoma growth in vitro and in vivo [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9811564
MeSH IDM0525661

Synonyms (80)

Synonym
AC-18117
tris(dibenzylideneacetone)dipalladium(0), 97%
51364-51-3
tris(dibenzylideneacetone)dipalladium(0)
T2184
tris(dibenzylideneacetone)dipalladium (o)
tris(dibenzylideneacetone)dipalladium
tris(dibenzylideneacetone)dipalladium (0)
pd2(dba)3
tris(dibenzylideneacetone) dipalladium
tris(dibezylideneacetone)dipalladium
BP-10487
GC10024
AKOS015888228
tris((1e,4e)-1,5-diphenylpenta-1,4-dien-3-one) dipalladium
mfcd00013310
tris(dibenzylideneaceton)dipalladium (0)
pd2(dba) 3
tris-(dibenzylideneaceton)-dipalladium(0)
tris(dibenzylidene acetone)dipalladium
tris(dibenzylidene-acetone)dipalladium(0)
tris(dibenzylideneacetone)-dipalladium(0)
tris(dibenzylideneacetone)di palladium(0)
tris(dibenzylidene acetone)dipalladium(0)
tris(dibenzylidene acetone)di-palladium
tris(dibenzylideneacetone)di-palladium(0)
tris(dibenzilideneacetone)dipalladium(0)
CYPYTURSJDMMMP-WVCUSYJESA-N
tris(dibenzylideneacetone)di-palladium (0)
tris(dibenzyl-ideneacetone)dipalladium(0)
tris(dibenzylideneacetone)-dipalladium
tris(dibenzylideneacteone)dipalladium(0)
tris (dibenzylidene acetone)dipalladium (0)
tris(dibenzylidene-acetone)dipalladium
tris(dibenzylidene acetone)dipalladium (0)
pd2 dba3
pd2 (dba) 3
tris(dibenzylideneacetone)-di-palladium (0)
tris(dibenzylideneaceton)dipalladium
tris(dibenzylideneacetone)-dipalladium (0)
tris-(dibenzylideneacetone)dipalladium
tris-(dibenzilideneacetone)dipalladium(0)
tris-(dibenzylideneacetone)dipalladium(0)
tris-(dibenzylideneaceton)-dipalladium
tris(dibenzylidene acetone)-dipalladium
tris(dibenzylidene acetone)dipalladium-(0)
tris(dibenzyl-ideneacetone)dipalladium (0)
tris(dibenzylideneacetone)dipaliadium(0)
tris-(dibenzylidene-acetone)dipalladium
tris-(dibenzylideneacetone)dipalladium (0)
tris(dibenzilideneacetone)dipalladium
tris (dibenzylidene acetone)dipalladium
tris(dibenzylidene-acetone)dipalladium (0)
tris (dibenzylideneacetone)dipalladium(0)
tris(dibezylideneacetone) dipalladium
tris (dibenzylideneacetone)dipalladium (0)
tris(dibenzylideneacetone)-di-palladium
tris-(dibenzylideneacetone)-dipalladium (0)
tris-(dibenzylideneacetone)di-palladium(0)
tris-(dibenzylideneacetone)di-palladium
tris(dibenzylideneaceton)dipalladium(0)
tris(dibenzylideneaceton)-dipalladium(0)
tris (dibenzylideneacetone)dipalladium
tris[dibenzylideneacetone]dipalladium (0)
tris(dibenzylideneactone)dipalladium
pd2 (dba)3
tris(dibenzyliden-eacetone)dipalladium(0)
tris-(dibenzylideneacetone)-dipalladium
pd2dba3
tris(dibenzylideneacteone)dipalladium (0)
tris(dibenzylideneacetorie)dipalladium(0)
tris(dibenzylideneacetone)palladium(0)
J-525135
CS-W007326
tris[dibenzylideneacetone]dipalladium(0), chemdose(tm) tablets, loading: 0.5mumol per tablet (1mumol pd per tablet)
GS-3242
tris(dibenzylideneacetone)dipalladium (pd2(dba)3)
tris(dibenzylideneacetone)dipalladium(0) 21.5% min pd grade
AMY11702
tris-dba palladium
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
chlorine
chloride : A halide anion formed when chlorine picks up an electron to form an an anion.		2.0710halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
aniline
[no description available]		2.0510anilines;
primary arylamine
acetyl chloride
[no description available]		2.0710acyl chloride
potassium carbonate
potassium carbonate : A potassium salt that is the dipotassium salt of carbonic acid.		2.0510carbonate salt;
potassium salt		catalyst;
fertilizer;
flame retardant
carbonates
Carbonates: Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed). carbonates : Organooxygen compounds that are salts or esters of carbonic acid, H2CO3.		2.0510carbon oxoanion
palladium
Palladium: A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.. palladium : Chemical element (nickel group element atom) with atomic number 46.		2.4920metal allergen;
nickel group element atom;
platinum group metal atom
phenyl acetate
phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid.		2.0710benzenes;
phenyl acetates
alkenes
[no description available]		2.0510
stannane
[no description available]		2.0710mononuclear parent hydride;
tin hydride
gamma-sitosterol
clionasterol : A member of the class of phytosterols that is poriferast-5-ene carrying a beta-hydroxy substituent at position 3.		2.11103beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols		marine metabolite;
plant metabolite
cytellin
cytellin: a phytosterol preparation of mainly B-sitosterol, that was marketed by Eli Lilly to lower cholesterol 1957 to 1982		2.1110
ConditionIndicatedRelationship StrengthStudiesTrials
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.6620
Glomerulonephritis, Lupus
[description not available]		02.2510
Lupus Nephritis
Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).		02.2510
Berger Disease
[description not available]		02.2510
Glomerulonephritis, IGA
A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.		02.2510
Malignant Melanoma
[description not available]		02.4920
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)		02.4920
Anoxemia
[description not available]		02.1310
Kahler Disease
[description not available]		02.1310
Hypoxia
Sub-optimal OXYGEN levels in the ambient air of living organisms.		02.1310
Multiple Myeloma
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.		02.1310
B-Cell Chronic Lymphocytic Leukemia
[description not available]		02.1310
Leukemia, Lymphocytic, Chronic, B-Cell
A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.		02.1310
Metastase
[description not available]		02.1310
Cancer of Pancreas
[description not available]		02.1310
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.		02.1310
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).		02.1310
B16 Melanoma
[description not available]		02.0410